梅拉诺科尔1受体 (MC1R):药理和治疗方面
Yoonwoo Mun1, Woohyun Kim1, Dongyun Shin1,2
1College of Pharmacy, Gachon University, 191 Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Republic of Korea.
International journal of molecular sciences
|August 12, 2023
概括
黑色皮质素1受体 (MC1R) 调节剂在治疗皮肤色素和炎症性疾病方面表现有前途. 研究强调了超越黑色素细胞的治疗潜力,为药物开发提供了新的途径.
科学领域:
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 黑色皮质蛋白调节压力,炎症和皮肤颜色.
- 黑色皮质素1受体 (MC1R) 是一个关键的G蛋白结合受体,参与这些过程.
- MC1R主要以其在皮肤色素和抗炎作用中的作用而闻名.
研究的目的:
- 审查与MC1R.相关的结构,信号和疾病.
- 讨论涉及MC1R调节器的治疗策略,包括合成和小分子.
- 探索针对MC1R的药物的更广泛的治疗应用,而不仅仅是色素障碍.
主要方法:
- 对MC1R结构,信号通路和相关疾病的文献综述.
- 对合成和小分子MC1R调节器的当前发展进行分析.
- 检查各种细胞类型中的MC1R表达及其对疾病治疗的影响.
主要成果:
- 包括稳定和小分子在内的MC1R调节器正在开发用于治疗用途.
- MC1R的作用超出了黑色素细胞的范围,在与炎症性疾病相关的细胞中表达.
- 针对MC1R提供了治疗各种疾病的潜力.
结论:
- 针对MC1R的药物对皮肤色素和炎症疾病都有显著的治疗潜力.
- 药物开发战略正在克服基于的治疗方法的局限性.
- 对MC1R调制的进一步研究可能会导致针对各种病理的新治疗方法.
相关概念视频
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Cholinergic Receptors: Muscarinic
2.4K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.4K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Opioid Receptors: Overview
1.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Transducer Mechanism: Nuclear Receptors
1.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K


